SCHEMBL2486440

SCHEMBL2486440

COc1ccc(C(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)[C@H](Nc2ccccc2)c2ccccc2)C3)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
CHRM3 P20309 10/20 0.43
CHRM2 P08172 3/20 0.43
POLB P06746 1/20 0.41
ATM Q13315 1/20 0.40
PDE2A O00408 1/20 0.40
PDE6D O43924 1/20 0.40
PDE8A O60658 1/20 0.40
PDE5A O76074 1/20 0.40
PDE9A O76083 1/20 0.40
PDE8B O95263 1/20 0.40
PDE6A P16499 1/20 0.40
PDE6G P18545 1/20 0.40
PDE4A P27815 1/20 0.40
PDE6B P35913 1/20 0.40
PDE6C P51160 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13240908 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTCHRM3CHRM2
SCHEMBL13282604 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTCHRM3CHRM2
SCHEMBL13240915 0.96 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTCHRM3CHRM2
Trifluoroacetic Acid SCHEMBL2482544 0.94 CHRM3 (0.41) ALDH1A1KDM4EMAPTCHRM3CHRM2
Trifluoroacetic Acid SCHEMBL2985286 0.94 CHRM3 (0.41) ALDH1A1KDM4EMAPTCHRM3CHRM2
SCHEMBL16649460 0.93 POLB (0.50) ALDH1A1KDM4EMAPTCHRM3CHRM2
SCHEMBL13240975 0.93 POLB (0.50) ALDH1A1KDM4EMAPTCHRM3CHRM2
SCHEMBL12072495 0.93 CHRM3 (0.40) CHRM3CHRM2PDE2APDE6DPDE8A
SCHEMBL15127401 0.93 CHRM3 (0.40) CHRM3CHRM2PDE2APDE6DPDE8A
Formic Acid SCHEMBL2484383 0.92 KDM4E (0.41) ALDH1A1KDM4EMAPTCHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376489-B1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMA SPA (IT) 2015-04-22 EP disclosed
US-8835682-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-09-16 US disclosed
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-08-01 US disclosed
US-8455646-B2 Alkaloid aminoester derivatives and medicinal composition thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-06-04 US disclosed
EP-2376489-A1 Alkaloid aminoester derivatives and medicinal composition thereof Chiesi Farmaceutici S.p.A. (IT) 2011-10-19 EP disclosed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US disclosed
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-08 US disclosed
WO-2010072338-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130196978-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG ALDH1A1 2693/4885KDM4E 2226/4885MAPT 1455/4885
US-20100173880-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHRM3, CHRM1, CHRNG ALDH1A1 2693/4885KDM4E 2226/4885MAPT 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.